These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23287897)

  • 21. Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity.
    Schaffer T; Flogerzi B; Schoepfer AM; Seibold F; Müller S
    J Crohns Colitis; 2013 Feb; 7(1):e1-10. PubMed ID: 22445443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
    Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
    Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM; Flogerzi B; Seibold-Schmid B; Schaffer T; Kun JF; Pittet V; Mueller S; Seibold F
    Am J Gastroenterol; 2009 Oct; 104(10):2508-16. PubMed ID: 19532127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients.
    Kim YS; Kim YH; Ye BD; Park DW; Kim JW; Han DS
    Clin Chim Acta; 2014 Feb; 429():206-11. PubMed ID: 24374090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased levels of serum omentin-1 in patients with inflammatory bowel disease.
    Yin J; Hou P; Wu Z; Nie Y
    Med Sci Monit; 2015 Jan; 21():118-22. PubMed ID: 25576244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
    Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
    J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of IL-1ra and Granzyme B as biomarkers in active Crohn's disease patients.
    Kim TJ; Koo JS; Kim SJ; Hong SN; Kim YS; Yang SK; Kim YH
    Biomarkers; 2018 Mar; 23(2):161-166. PubMed ID: 28972805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease.
    Kohoutova D; Drahosova M; Moravkova P; Rejchrt S; Bures J
    BMC Gastroenterol; 2014 Dec; 14():190. PubMed ID: 25551469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
    Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.
    Forcione DG; Rosen MJ; Kisiel JB; Sands BE
    Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.
    Smids C; Horjus Talabur Horje CS; Groenen MJM; van Koolwijk EHM; Wahab PJ; van Lochem EG
    Scand J Gastroenterol; 2017 Oct; 52(10):1104-1112. PubMed ID: 28661185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
    Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
    Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease.
    El-Matary W; Dupuis K; Sokoro A
    Acta Paediatr; 2015 Aug; 104(8):827-30. PubMed ID: 25877674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2.
    Komorowski L; Teegen B; Probst C; Aulinger-Stöcker K; Sina C; Fellermann K; Stöcker W
    J Crohns Colitis; 2013 Nov; 7(10):780-90. PubMed ID: 23140841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease].
    Kim JE; Kim KS; Seo JK
    Korean J Gastroenterol; 2003 Oct; 42(4):297-302. PubMed ID: 14634349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.